Back to HPTX Stock Lookup

HPTX – Analyst Ratings

Mar 18, 2014 04:18 PM Cantor Fitzgerald Starts Hyperion Therapeutics (HPTX) at Buy
Feb 28, 2014 07:52 AM Hyperion Therapeutics (HPTX) Target, Estimate Raised at Needham & Company
Aug 15, 2013 11:04 AM Hyperion Therapeutics (HPTX) PT Lifted to $35 at Needham & Company
Apr 8, 2013 07:31 AM JMP Securities Starts Hyperion Therapeutics (HPTX) at Market Outperform
Feb 26, 2013 09:06 AM Needham & Company Maintains Buy on Hyperion Therapeutics (HPTX) Post Q4
Feb 4, 2013 03:12 PM Needham & Company Raises PT on Hyperion Therapeutics (HPTX) to $25 after FDA Approval for Ravicti
Aug 20, 2012 09:58 AM Cowen Starts Hyperion Therapeutics (HPTX) at Outperform
Aug 20, 2012 07:57 AM Leerink Swann Starts Hyperion Therapeutics (HPTX) at Outperform; Attractive Opportunity in Orphan Drug Model
Aug 20, 2012 07:36 AM Needham & Company Starts Hyperion Therapeutics (HPTX) at Buy; Commercial Opportunity for Navicti

Back to HPTX Stock Lookup